← All stocks

NRX Pharmaceuticals, Inc.

NRXP Net buying
CIK 0001719406 #4115 in the set updated 21 Sep 2026
Bought (120 mo)
$6.84M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.97M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$2.97M
14 of 14 sales
Net
+$3.87M
+$3.87M against sales at will

By person

16 insiders · 39 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Javitt Jonathan C
Chairman and Chief Scientist
$5.94M (4)
$400.00K (1)
+$5.54M
14,406,631
$16.86M
Javitt Daniel C.
10% owner
$1.35M (9)
−$1.35M
23,606,657
$27.62M
+69.0%
Hurvitz Chaim
Director
$535.03K (4)
+$535.03K
778,443
$910.78K
Besthof Robert
Interim CEO
$470.40K (1)
−$470.40K
23,710
$27.74K
Daigneault Alessandra
General Counsel & Secretary
$442.00K (1)
−$442.00K
31,584
$36.95K
Polar Asset Management Partners Inc. entity
10% owner
$312.32K (1)
−$312.32K
488,036
$571.00K
−5.7%
ACKERMAN RICHARD
President and CEO
$225.00K (1)
(1)
+$225.00K
272,500
$318.83K
−84.4%
Willard Stephen H
CHIEF EXECUTIVE OFFICER
$58.50K (1)
+$58.50K
50,000
$58.50K
VAN VOORHEES SETH
CHIEF FINANCIAL OFFICER
$51.22K (4)
+$51.22K
62,714
$73.38K
+282.9%
Flynn Patrick John
Director
$14.66K (5)
+$14.66K
439,500
$514.21K
Gorovitz Aaron
Director
$11.20K (1)
+$11.20K
130,014
$152.12K
+143.8%
BRAC Lending Group LLC entity
10% owner
562,435
$658.05K
−60.7%
Big Rock Partners Sponsor, LLC entity
10% owner
519,315
$607.60K
+4.4%
Troy Daniel
Director
43,093
$50.42K
McMaster Herbert Raymond
Director
18,300
$21.41K
Glied Sharon
Director
13,168
$15.41K

No percentages here. This company's share count has moved by a factor of 3.6 over the window, from 12,094,094 to 43,295,767 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Daigneault Alessandra
2 Sep 2021
General Counsel & Secretary
Exercised, kept
13,164
$3.07
$40.41K
Daigneault Alessandra
2 Sep 2021
General Counsel & Secretary
Exercised, kept
18,420
$3.07
$56.55K
McMaster Herbert Raymond
26 Aug 2021
Director
Exercised, kept
18,300
$2.22
$40.63K
Daigneault Alessandra
19 Aug 2021
General Counsel & Secretary
Exercised, kept
27,395
$3.07
$84.10K
Besthof Robert
16 Aug 2021
Chief Comm. & Patient Officer
Exercised, kept
63,710
$0.20
$12.74K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 14
Transactions with no price 1
Shares from compensation/vesting 34,883,430
Sales filed before the plan box existed 14
History held since 4 Dec 2017